LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Research and development: 124.3K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +82.6%
Financial Fact:
Research and development: 124.3K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
- Microsoft (MSFT) call put ratio 2.1 calls to 1 put as share price pulls back
- Cerebras Systems (CBRS) call put ratio 1 call to 1.1 puts into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
